Postoperative analgesic effect of bupivacaine infiltration following lumbar disc surgery
Abstract
Objectives: Effectiveness of 0.5% bupivacaine administered onto dura, under lumbar superficial fascia and subcutaneous tissue on postoperative pain control was analyzed in patients undergoing lumbar microdiscectomy.
Methods: Sixty adult patients scheduled to undergo elective, single-level lumbar discectomy were randomly divided into four groups: the control group (Control), the subcutaneous tissue group (Group C), which received 20 ml of 0.5% bupivacaine in the subcutaenous tissue, the superficial fascia group (Group F), which received 12 ml bupivacaine in the subcutaneous tissue and 8 ml in the space below the lumbar superficial fascia, and the dura group (Group D), which received a total of 20 ml (100 mg) of bupivacaine, consisting of 10 ml in the subcutaneous tissue, 8 ml in the space below the lumbar superficial fascia, and 2 ml on the dura. Visual Analog Scale Values (VAS) on postoperative 0, 15, 30, 45 minutes, at 1, 2, 4, 6, 12 and 24th hour and time of the first analgesic need were evaluated for all patients and recorded.
Results: While mean VAS value measured at min 0 (as soon as the patient awakened) was 2.3 ± 1.2 in Group D; it was 2.7 ± 0.9 in Group C; 2.7 ± 1.0 in Group F and 3.1 ± 0.6 in control group (p = 0.232). At the end of 1th hour, mean VAS value was recorded as 2.8 ± 1.0 in Group D; 3.6 ± 1.5 in Group C; 3.6 ± 1.1 in Group F and 4.4 ± 1.1 in control group (p = 0.005). In Group D, 0.5% bupivacaine administered as 2, 8, 10 ml onto dura, fascia and subcutaneously was detected to provide significantly lower VAS values and significantly longer first analgesic need time.
Conclusions: 0.5% bupivacaine administered onto dura, under lumbar superficial fascia and in subcutaneous tissue was detected to be a simple, effective and safe method in lumbar microdiscectomy operations.
Keywords
References
- [1] Apostolides PJ, Jocobowitz R, Sonntag VKH. Lumbar discectomy microdiscectomy: “the gold standard”. Clin Neurosurg 1995;43:228-38.
- [2] Erdine S. Postoperatif analjezi. In: Erdine S, ed. Ağrı sendromları ve tedavisi. 2nd ed., İstanbul: Gizben Maatbacılık, 2003;33-3.
- [3] Nagy I, Rice ASC. Applied physiogy of inflammatory pain. In: Rowbotham DJ, Macinteyre PE, eds. Clinical Pain Management: Acute Pain. London: Arnold Publishers, 2003:17-47.
- [4] Kantor TG. Physiology and treatment of pain and inflammation: analgesic effects of flurbiprofen. Am J Med 1986;80(Suppl 1);3-9.
- [5] Avtan L, Berber E, Avcı C. Laparoskopik cerrahide postoperatif analjezi. Ağrı Dergisi 1996;8:22-5.
- [6] Benumof JL. Management of postoperative pain. In: Benumof JL, ed. Anesthesia for Thoracic Surgery. 2nd ed.. Philedelphia, W.B: Sounders Company, 1995:756-74.
- [7] Mitchell RW, Smith G. The control of acute postoperative pain. Br J Anaesth 1989;63:147-58.
- [8] Schenk MR, Putzier M, Kügler B, Tohtz S, Voigt K, Schink T, et al. Postoperative analgesia after major spine surgery: patient-controlled epidural analgesia versus patient-controlled intravenous analgesia. Anesth Analg 2006;103:1311-7.
Details
Primary Language
English
Subjects
Surgery , Anaesthesiology , Neurosciences
Journal Section
Research Article
Authors
Tamer Tunçkale
*
0000-0002-4534-0864
Türkiye
Numan Karaarslan
0000-0001-5590-0637
Türkiye
Melek Tunçkale
This is me
0000-0002-7777-5993
Türkiye
Tezcan Çalışkan
0000-0001-7735-0584
Türkiye
Publication Date
September 4, 2019
Submission Date
April 9, 2018
Acceptance Date
December 14, 2018
Published in Issue
Year 2019 Volume: 5 Number: 5